The purpose of the present study was to de termine effects of angiotensin (ANG) II on the cerebral circulation. We measured the pial artery pressure (PAP) and CBP in anesthetized rabbits. ANG II (5 f.1g/min) was infused into each carotid artery, and systemic arterial pressure was maintained constant. During infusion of ANG II, there was a significant increase in CBF and fall of PAP, with no change in the large artery resistance (LAR) and a significant decrease in the small vessel re sistance (SVR). To investigate whether prostaglandin modulated the ANG II-induced increase in CBF, indo methacin was administered (10 mg/kg i. v .) in another group of animals. Indomethacin itself reduced PAP and increased LAR significantly without changing CBF or SVR. Indomethacin did not attenuate the effects of ANG II on the cerebral circulation. The CMR02 was assessed Angiotensin (ANG) II contracts cerebral arteries in vitro (Edvinsson et aI., 1979). However, when the cerebral arteries are precontracted by prosta glandin (PG)Fz a , which exists in vivo, ANG II re laxes the cerebral arteries, and this relaxation re sponse is reversed to a contraction by adding cy clooxygenase inhibitor (Toda and Miyazaki, 1981) . Studies in vivo suggest that intravenous ANG II can constrict large cerebral arteries with a small reduc tion in CBF (Faraci et aI., 1988) or can decrease CBF markedly (Reynier-Rebuffel et aI., 1983). In a human study, intracarotid infusion of ANG II failed to alter the CBF while the systemic arterial pressure (SAP) was elevated moderately to increase the ce-318 during ANG II intracarotid infusion in another group of rabbits. CMR02 did not change during infusion of ANG II. We also investigated effects of u-atrial natriuretic pep tide (ANP) on the cerebral circulation. Infusion of ANP (1 f.1g/min) decreased LAR by 28% (p < 0.05) without alter ing SVR. Administration of ANG II after ANP tended to reduce LAR (p > 0.05), with a significant decrease in SVR. The results of the present study suggest that high doses of ANG II can produce cerebral vasodilatation, particularly of small vessels. Blood-borne ANP dilated the large arteries of the cerebral circulation selectively and neither interfered with nor reversed the ANG 11induced increase in CBF. Key Words: Angiotensin II-u Atrial natriuretic peptide-Cerebral blood flow-Cere bral metabolic rate for oxygen-Indomethacin-Micro circulation.
Summary:
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rebrovascular resistance (CVR) (Olesen, 1972) . In the acute hypertensive state caused by hyperan giotensinemia, lowering of blood pressure to a nor mal level seems to have caused cerebral infarction in several clinical cases (Haas et aI., 1983 (Haas et aI., , 1985 . Thus, a higher concentration of ANG II may con strict cerebral arteries and produce a profound re duction in CBF.
The first goal of this study was to examine re sponses to a higher dose of ANG II in the nor motensive state to determine whether vasodilator responses could be unmasked, as predicted from studies in vitro; or vasoconstrictor responses, which decrease CBF remarkably, could be proved. Second, we calculated CMROz to determine whether changes in CBF were associated with, and presumably secondary to, changes in cerebral me tabolism. Third, we examined the effects of ANG II after administration of indomethacin to determine whether PGs mediate or modulate cerebral vascular responses to ANG II. Effects of ANG II on the brain (Shirakami et aI., 1988) , endocrine organ (Vierhapper et aI., 1986) , and blood pressure (Yasu jima et aI., 1986) may be modulated by a-atrial na triuretic peptide (ANP). The final goal of this study was to determine whether ANP modulates cerebral vascular responses to ANG II.
In these studies we measured microvascular pres sure as well as CBF. This approach, which allows calculation of the resistance of large and small ce rebral vessels, is a sensitive method for the detec tion of cerebral vascular responses that cannot be detected by the measurement of CBF alone (Faraci and Heistad, 1990) .
METHODS
We used 40 Japanese white rabbits weighing 2.0-2.9 kg. Anesthesia was induced with sodium thiamylal and main tained with intravenous chloralose (75 mg/kg). The rab bits were immobilized with pancuronium bromide (0.1 mg/kg), intubated, and ventilated mechanically with room air and supplemental oxygen. The body temperature was kept at 37-38°C with a homeostatic blanket servo controlled by a rectal temperature probe. For monitoring the SAP as well as sampling arterial blood for the blood gases and pH, a catheter was inserted into the femoral artery and its tip was advanced and placed in the descend ing aorta. Blood gases and pH were measured periodi cally employing a pH/gas analyzer (ABL 300; Radiome ter, Copenhagen). We adjusted Pac02 and Pa02 by chang ing the ventilation rate or amount of supplemental oxygen. Nevertheless, several animals displayed hypo capnia after ANG II infusion. Rabbits that showed marked hypocapnia (P aco2 < 30 mm Hg) were excluded from the present study. To obtain reference blood sam ples for determination of the blood flow by the micro sphere method, catheters were inserted into both axillary arteries. For the infusion of saline or peptide, catheters were inserted into both external carotid arteries retro gradely. The distal parts of the external carotid arteries were ligated. A catheter was also inserted into the left atrium to inject the microspheres. Catheters were in serted into the other femoral artery for exsanguination to maintain the SAP during ANG II infusion and into the femoral vein for the injection of drugs. A ligature, which was subsequently tightened during the infusion of ANP to prevent hypotension, was placed loosely around the de scending aorta, below the tip of the aortic catheter. The method for keeping SAP from falling was compatible with one reported elsewhere (Tamaki et aI., 1986a; Faraci et aI., 1988) . To reduce the changes in cerebral volume with ventilation, a right thoracotomy was performed. Heparin (1,000 U/kg) was given as an anticoagulant. Lidocaine was applied to the wounds to lessen the painful stimuli during manipulation.
Microspheres of 15 J-Lm in mean diameter labeled with 46SC, 85Sr, 11 3 Sn, 1 2 51, and 141Ce (New England Nuclear, Boston, MA, U.S.A.; or 3M, Minneapolis, MN, U.S.A.) were employed to measure CBF. The microspheres were vortexed, sonicated in warm water for > 15 min, and vor texed again for -2-3 min just before injection. Two to three nuclides were used and the order of the micro spheres was determined by a microcomputer with ran domization program. Microspheres were injected into the left atrium in 20 s. We injected 0.18-0.51 x 106 micro spheres, which was compatible with other studies. The injection line was flushed with 1-2 ml of saline. Reference blood samples were withdrawn from the axillary arteries at 1.03 mllmin for 10 s before and until 1 min after the injection of spheres using an infusion/withdrawal pump (Harvard Apparatus, South Natick, MA, U.S.A.). Each rabbit was killed with intravenous KCI at the end of the experiment. The brain was removed, dissected, and weighed. The resultant tissue samples and blood samples were counted in a ,(-counter with a built-in spillover pro gram (Aloka, ARC-2000, Tokyo, Japan). Blood flow (BF) to the tissue was calculated from the following equation: BF = (counts/g tissue x 100 x withdrawal rate of refer ence blood samples) -;-counts in reference blood sam ples.
Pial artery pressure measurement
A left parietal craniotomy was performed with a rongeur. A wax dam was formed around the craniotomy and supported with dental acrylic. Artificial cerebrospinal fluid bubbled with a mixture of 6% CO2 6% O2 88% N2 was infused to the dural opening to superfuse the cerebral blood vessels. The dura was punctured with a needle and resected with ophthalmic scissors. The tips of glass mi cropipets were sharpened and beveled to a diameter of 3-6 J-Lm. The micropipets were filled with 1.5 M NaCl solution. The microvascular pressure was measured with a servo-nulling device (model 4A; Instruments for Phys iology and Medicine, San Diego, CA, U.S.A.). With a micromanipulator (Leitz, Rockleigh, NJ, U.S.A.), the tip of the micropipet was placed in the pool of cerebrospinal fluid, and a zero value was established. The micropipet was inserted into the lumen of a pial artery of 99 ± 16 J-Lm (mean ± SD) in diameter. When marked pial arterial con striction or hemorrhage occurred on insertion of the mi cropipet, the data for the animal concerned were ex cluded from the study. The diameter of the pial arteries was measured using a computerized width analyzer con nected to a television camera (model CIOOO + C1170; Hamamatsu Photonics, Hamamatsu, Japan), which was mounted on an Olympus microscope (SZH), and a video monitor. The value of the diameter was recorded on an eight-channel polygraph (Nihon Kohden, Tokyo, Japan) with the SAP and pial artery pressure (PAP). The pH of the CSF was monitored with a pH meter (model 81; Yokogawa Electric Co., Tokyo, Japan). For dissolving drugs or preparing saline or artificial CSF, ultrapure wa ter was employed. To calculate large artery resistance (LAR) and small vessel resistance (SVR), the following equations were used: LAR = (SAP -PAP) -;-CBF and SVR = PAP -;-CBF, respectively (Baumbach and Heis tad, 1983; Shima et aI., 1983) .
Experimental protocol
PAP and CBF were measured during infusion of vehi cle (0.9% NaCI) as a control and ANG II in 11 rabbits (group 1). ANG II, purchased from the Peptide Institute Inc. (Osaka, Japan), was freshly dissolved in saline and placed in a plastic syringe. The ANG II (5 J-Lg/min) was infused into both common carotid arteries with an infu sion pump (STC-521; Terumo, Tokyo, Japan). The vol ume of infusate given was 0.5 ml/min. During ANG II infusion, -30-40 ml of blood was withdrawn to keep SAP constant. The blood was reinfused when SAP fell. The saline or ANG II was slightly warmed and infused for 4 min before micro spheres were injected, and the infusions were continued until the end of the withdrawal of refer ence blood. In two rabbits, both cervical sympathetic ganglia were severed to determine the role of the sympa thetic nerves. The responses of SAP, PAP, and CBP to ANG II in the denervated rabbits were essentially the same as those in the non denervated rabbits so that the results for these animals were included in this group. Dur ing infusion of saline, the arterial Pe02 was 40 ± 3 mm Hg, P02 was 115 ± 20 mm Hg, and pH was 7.27 ± 0.06. The blood gases and pH during ANG II infusion did not differ significantly from those during saline infusion. The gases and pH of the artificial CSP were as follows: Pe02, 39 ± 5 mm Hg; P02, 82 ± 2 mm Hg; and pH, 7.29 ± 0.06. To confirm that saline is inactive on CBP and the seg mental CVRs, we measured CBP without and with infu sion of saline using the other four rabbits. Then, bilateral internal carotid arteries were occluded to observe the ef fect of lowering the PAP on the segmental CVRs. CBP was measured 5 min after the carotid occlusion. Thereaf ter, the carotid arteries were reopened. ANG II (5 fLg/ min) was infused into the carotid arteries without bleed ing to see how far SAP was increased. SAP increased -50 mm Hg from basal condition.
In a separate group of rabbits (n = 8, group 2), indo methacin dissolved with NaC0 3 (three parts of indometh acin to one part of NaC0 3 ) was infused intravenously over a period of 3 min (10 mg/kg) using an infusion pump. The dose of indomethacin seemed sufficient to block the cyc\ooxygenase pathway (Busija and Heistad, 1983) . Af ter a wait of at least 15 min, saline was given, and ANG II (5 fLg/min) was then infused intracarotidly. The CBP levels were measured during saline infusion, before and after indomethacin administration, and during ANG II infusion. The arterial Pe02 was 42 ± 3 mm Hg, the arterial P02 was 113 ± 19 mm Hg, and the pH was 7.25 ± 0.05 in the control period, and the values were not altered during the saline or ANG II administration after indomethacin. The gases and pH of the CSP were as follows: Pe02, 34.1 ± 0.5 mm Hg; P02, 69 ± 9 mm Hg; and pH, 7.32 ± 0.03.
With another eight rabbits (group 3), the CMR02 was determined. The animals were anesthetized, immobi lized, and ventilated mechanically. Craniotomy was per formed to expose the superior sagittal sinus. The dura over the sinus was carefully dissected using a microsur gery blade. A 27-gauge intracatheter was inserted into the sinus and fixed to the cranium with dental acrylic. Cere bral venous blood was taken anaerobically through the intracatheter. The arterial blood pH and gases and cere bral venous P02 were determined with an ABL pH/gas analyzer. The saturation of O2 and hemoglobin concen tration of both the arterial and the cerebral venous blood were assessed with a hemoximeter (OSM2; Radiometer, Copenhagen, Denmark). The O2 content was then calcu lated from the values for the O2 saturation, hemoglobin concentration, and cerebral venous P02• The microsphere technique was employed to estimate the CBP in the ce rebrum, which drains into the sagittal sinus. Based on the values for the CBP and O2 content in the arterial and cerebral venous blood, the CMR02 was calculated from the following equation: CMR02 = CBP X (CA -Cy)/ 100, where C A is the O2 content in the arterial blood and Cy is the O2 content in the cerebral venous blood. CMR02 was measured during saline and ANG II (5 fLg/ min) intracarotid infusion. The total renal blood flow and coronary blood flow were also determined. The kidneys J Cereb Blood Flow Metab, Vol, 12, No, 2, 1992 and apex of the heart (left ventricle) were removed, weighed, and their radioactivities counted using a 'Y-counter. The arterial Pe02 was 44 ± 2 mm Hg, the P02 was 117 ± 23 mm Hg, and the pH was 7.30 ± 0.10 during saline infusion, and these values were not altered during ANG II infusion. In this series, the microvascular pres sure was not determined.
In another nine rabbits (group 4), the CBP was mea sured during saline, ANP, and ANG II intracarotid infu sion. We purchased ANP (rat, 1-28) from the Peptide Institute Inc. This rat ANP (1 fLg/min) dissolved in saline was infused 8 min before the injection of microspheres. Soon after the end of the ANP administration (within 1 min), ANG II (5 fLg/min) was infused for 4 min before the microsphere injection. Infusion of saline, ANP, and ANG II was continued until the end of the withdrawal of refer ence blood. In this group, the arterial Pe02 was 43 ± 2 mm Hg, the P02 was 143 ± 30 mm Hg, and the pH was 7.24 ± 0.04 during saline infusion, and these values did not change significantly during ANP and ANG II infu sion. The gases and pH of the artificial CSP were as fol lows: Pe02, 38 ± 2 mm Hg; P02, 84 ± 8 mm Hg; and pH, 7.24 ± 0. 02. The SAP was maintained by partial occlusion of the descending aorta during ANP infusion and by ex sanguination during ANG II infusion.
Statistical analysis
The data are expressed as means ± SD. To compare the data obtained during saline and ANG II infusion, the paired t test was used. When more than one comparison was made, the paired t test with Bonferroni correction was employed.
RESULTS

Effects of ANG II
While the SAP was maintained during ANG II infusion, PAP began to decrease at 1-2 min after the beginning of ANG II. Figure I illustrates the SAP, PAP, and CBF to the left parietal region during sa line (control) or ANG II infusion (group 1). Al though the SAP was maintained, PAP fell markedly (p < 0.05) during ANG II infusion. The pressure gradient between SAP and PAP during the control period was 45 ± 15 mm Hg and increased to 60 ± 13 mm Hg during ANG II infusion (p < 0.05). As shown in Fig. 1 , the peptide increased the CBF from 44 ± 16 ml/min/ 100 g (during saline) to 61 ± 29 mlimin/lOO g (during ANG II; p < 0.05). Changes of segmental CVRs due to ANG II are summarized later. In addition, CBF and segmental CVRs were not influenced by saline infusion, which suggested that saline is inactive on CBF and the segmental CVRs. During the bilateral carotid occlusion, PAP decreased 9 mm Hg, LAR increased 23%, and SVR decreased 18%, while SAP and CBF did not change. Figure 2 presents a summary of values for SAP, PAP, CBF during saline infusion before indometh acin, and saline (control) and ANG II infusion after (PAP) . and CBF to the left parietal cortex during saline (CONT.) and an giotensin (ANG) II infusion while con trolling the SAP by exsanguination (group 1). Note that CBF increased while PAP decreased significantly. *p < 0.05 versus control. The data are ex pressed as means ± SD. mmHg 120 SAP indomethacin administration (group 2). Indometha cin produced a small but significant decrease in mi crovascular pressure, while the SAP and CBF re mained unchanged. Even after indomethacin, ANG II decreased PAP and increased CBF significantly (p < 0.05). Thus, indomethacin did not alter the effects of ANG II on the PAP and CBF.
As shown in Table 1 , the CMR02 was not altered while the CBF was again increased during infusion of ANG II (group 3). The total renal blood flow during ANG II infusion decreased to 13% of that ml / min /IOOg D CO T. _ ANG II PAP 100 * CBF during saline (p < 0.05). The coronary blood flow was also decreased, but not significantly.
Effects of ANP
A summary of the SAP, PAP, and CBF values during saline (control), ANP, and ANG II immedi ately after ANP infusion is presented in Fig. 3  (group 4) . During ANP infusion, the microvascular pressure increased while the SAP was maintained constant. The value of PAP was restored to the con trol level due to ANG II soon after the ANP admin- pial artery pressure (PAP). and CBF to the left parietal cortex during saline infusion before in domethacin. saline (CONT.). and angiotensin (ANG) II infu sion after indomethacin admin istration (group 2). SAP during ANG II infusion was controlled by exsanguination, Indometha cin decreased PAP slightly but significantly. whereas it did not change CBF. Indomethacin did not influence the effect of ANG II on PAP and CBF; i.e., de crease in PAP and increase in CBF. #p < 0.05 versus saline before indomethacin adminis tration; *p < 0.05 versus con trol. The data are expressed as means ± SD. 
Saline
ANG II 97 ± 9 99 ± 10 40 ± 12 3.5 ± 2.0 3.4 ± 1.2 0.5 ± 0.5a
2.1 ± 0.5 1.8 ± 0.8 55 ± 16a
3.5 ± 0.9
Values are means ± SD for eight rabbits. a p < 0.05 vs. saline.
istration. The pressure gradient between SAP and PAP during the control period was 42 ± 11 mm Hg, declined to 34 ± 9 mm Hg (p < 0.05) during ANP infusion, and was restored to 43 ± 11 mm Hg during ANG II. During ANP infusion, CBF increased but the change was not significant, while ANG II ad ministration augmented the CBF significantly.
Segmental CVRs
As summarized in Fig. 4 , ANG II selectively low ered SVR (p < 0.05), and the effects of ANG II on the segmental CVRs were not influenced by indo methacin. In contrast, ANP lowered LAR selec tively (p < 0.05), but did not inhibit the effects of ANG II on the segmental CVRs.
DISCUSSION
We demonstrated that a high concentration of ANG II increased the CBF and lowered the PAP in the normotensive state, resulting in a selective de crease of the SVR in the present study. Lowering of PAP after carotid occlusion decreased SVR, prob ably owing to the autoregulatory mechanism; how ever, it is unlikely that the same mechanism in- PAP creases CBF. Therefore, ANG II seemed to dilate small cerebral vessels actively, which resulted in a remarkable reduction in SVR in the present study.
Our results showed a significant decrease in total renal blood flow due to ANG II, as has been re ported by others (Hollenberg et al., 1972) . In the heart, the blood flow was also decreased in this study, as described elsewhere (Marcus, 1983 ), but did not reach significance. Thus, the tissue flows, except to the brain, were influenced by ANG II administration as expected. These findings suggest that our method of measuring the organ blood flow or protocol for the infusion of saline and ANG II was appropriate. The results of our study also indi cated that the dilatative effect due to ANG II is specific to the cerebral circulation.
Effect of ANG II Hill and Larkins (1989) found that the small ar tery (third order) of the cremaster muscle dilated following transient constriction after ANG II appli cation in vivo. Therefore, the time factor could play an important role in detecting the dilatation. Hill and Larkins (1989) also measured the 6-keto- unchanged during infusion of ANG II and ANG II after indomethacin. In contrast, LAR declined significantly owing to ANP and LAR decreased but did not reach sta tistical significance during ANG II infu sion immediately after ANP. SVR was re duced owing to ANG II, and the decrease was not influenced by indomethacin ad ministration. SVR was not altered owing to ANP infusion; furthermore, reduction in SVR due to ANG II was not influenced by previous infusion of ANP. The data are expressed as means ± SO. *p < 0.05 ver sus control.
PGF2cx' a stable degradation product of PGI2, to find an increase of the product. Toda and Miyazaki (198 1) speculated that ANG II releases PGI2 from the arterial wall because ANG II-induced relaxation of the cerebral artery was reversed to a contraction following addition of cyclooxygenase inhibitor in their in vitro experiments. These findings suggest that ANG II accelerates the production of PGI2 in the vascular wall or accelerates the release of PGI2 from the vascular wall. Despite these results, our experiments failed to demonstrate an inhibitory ac tion of indomethacin against the effects of ANG II on the cerebral circulation. It is also interesting to note that indomethacin itself lowered PAP slightly, but was associated with a remarkable increase of LAR in the present experiments. These observa tions imply that vasodilator PGs (PGI2 or PGE2) distend the large arteries, so that reduction of them increases the LAR. The effects of the PGs on the segmental CVR need to be elucidated further.
In vitro experiments also showed that the distal segment of the middle cerebral artery was dilated more than the proximal one by ANG II, indicating that smaller vessels generate PGI2 much more readily than larger ones (Toda and Miyazaki, 1984) . This finding is compatible with the results of our study, which demonstrated a selective reduction of -� SVR due to ANG II. In vivo, the total endothelial surface area of the smaller vessels is greater than that of the larger arteries, so that the former contact more ANG II molecules than the latter. This struc tural difference may have served to enhance the small vessel dilatation due to ANG II in our study.
Since ANG II hardly permeates the blood-brain barrier (Volicer and Loew, 197 1) , comparisons of the effects of ANG II between in vitro and in vivo are difficult. Nevertheless, ANG II clearly dilated cerebral vessels in the present study as well as in the in vitro study. Toda and Miyazaki (198 1) ex plained that ANG II dilates cerebral vessels through ANG II receptors since ANG II analogues block the dilatative action of ANG II. Another possibility ex ists that augmentation of CBF could be accompa nied by an increased cerebral metabolism due to ANG II. A combination of increased CBF, de creased PAP, decreased SVR, and slightly changed LAR in the normotensive state has also been ob served in seizure (Tamaki et aI., 1986b) . Under such conditions, the cerebral metabolism is increased. Grammas et ai. (198 1) proved that ANG II induced a disruption of the blood-brain barrier without hy pertension. Since the cerebral metabolism is in creased in the area of disruption of the blood-brain barrier (Rapoport et aI., 198 1) , CBF may be in-creased with coupling to the metabolism. On the other hand, the cerebral metabolism may have been changed by ANG II through stimulation of neuronal cells in the area postrema, subfornical body, or su praoptic crest, which lack the blood-brain barrier and display chemosensitivity to ANG II (Bradbury, 1979) . The CMR02 value during ANG II infusion, however, did not vary from that of the control pe riod in this study, so it seems unlikely that the ANG II-induced increase of CBF was attributable to an increased metabolism.
Thus, the mechanism of vasodilatation due to ANG II in the present study is unclear. A very re cent cranial window study has demonstrated that methylene blue can attenuate ANG II-induced dila tation of the pial artery; moreover, vessels that had their endothelium damaged by light plus dye injury were constricted, while vessels with an intact en dothelium were dilated by ANG II (Haberl et aI., 1990) . Therefore, it is possible that EDRF produc tion was stimulated by ANG II to dilate the cerebral vessels.
Effects of ANP
In vitro study has shown that rat cerebral arteries contracted by PGF2<x or serotonin did not undergo any relaxation in response to ANP (Osol et aI., 1986) . In contrast, an in vivo study has revealed that the diameter of the pial artery can be dilated by microapplication of ANP surrounding the vessels in the cat (Macrae et aI., 1987) . The effect of ANP on the cerebral vessels is thus also controversial. Our experiments revealed that CBF increased, but the change did not reach statistical significance even after intracarotid administration of large doses of ANP, whereas LAR decreased remarkably with an unchanged SVR in the normotensive state. In the peripheral circulation, ANP also selectively dilates large vessels (Faber et aI., 1988) , which is compat ible with our results.
Although many studies have demonstrated that ANP acts as an inhibitor of ANG II (Vierhapper et aI., 1986; Yasujima et aI., 1986; Shirakami et aI., 1988) , there is also some evidence of an analogous action of both ANP and ANG II. In salt-loaded ducks, administration of ANG II increased the plasma epinephrine and stimulated water excretion. Both responses were augmented by coinfusion of ANP, while ANG II-induced hypertension re mained uninfluenced (Wilson, 1987) . In our study, preinfusion of ANP did inhibit the decline in PAP due to ANG II below the level in the control period, although it did not interfere with the increase in CBF (Fig. 3) . During ANG II infusion after ANP, SVR fell significantly and LAR was also decreased, J Cereb Blood Flow Metab, Vol. 12, No. 2, 1992 but the change did not reach statistical significance (Fig. 4) . Hence, blood-borne ANP neither interferes with nor reverses the effect of ANG II on the cere bral circulation, with the exception of the PAP changes.
In conclusion, ANG II increased the CBF and decreased the SVR without changing the LAR. Blood-borne ANG II may regulate the blood vessel tone, not only by constriction as described previ ously but also by dilatation as indicated in this study. Blood-borne ANP did not exert an antago nistic action against the ANG II in the cerebral cir culation; rather, it cooperated to reduce the CVR.
